Global Neurovascular Devices or Interventional Neurology Market

Report ID : 1345 | Published : 2022-07-27 | Pages: | Format:

The Global Neurovascular Devices or Interventional Neurology market size was valued at US$ 2.66 billion in 2021 and is expected to grow at a compound annual growth rate (CAGR) of 9.13% from 2022 to 2030. Neurovascular conditions encompass intracranial aneurysms, ischemic stroke, subarachnoid hemorrhage, cavernous malformations, arteriovenous malformations, carotid disease, intracerebral hemorrhage, and moyamoya disease. Neurovascular devices treat a blood vessel or blood flow that impairs brain and nervous system function.

Multiple factors drive the growth of the neurovascular devices or interventional neurology market, including the increasing prevalence of neurovascular diseases, the development of new neurovascular devices, improved medical reimbursement policies, rising demand for safe and effective neurovascular devices, a well-established healthcare infrastructure, and an increase in research and development activities for neurovascular therapies. Besides this, growing patient demand for minimally invasive treatments results in the innovation and launch of neurovascular devices, which is likely to drive the growth of the neurovascular devices market. For instance, in August 2020, Stryker Corporation (US) launched the Surpass Evolve Flow Diverter and received U.S. FDA approval for the same. This diverter is the first 64-wire cobalt-chromium flow diverter in the U.S. designed to re-direct blood flow and promote aneurysm healing. However, the elevated cost of neurovascular devices and treatments may restrain the market’s growth.

The neurovascular devices or interventional neurology market is classified based on the products, end-users, and region. The products segment is categorized into aneurysm coiling & embolization devices (embolic coils, flow diversion devices, liquid embolic agents), cerebral balloon angioplasty & stenting systems (carotid artery stents, embolic protection, balloon catheters), support devices (microcatheters and guidewires), and neurothrombectomy devices (clot retrievals, suction & aspiration, snares). By end-users, the market is segmented into hospitals & surgical centres, ambulatory care centres, and research laboratories & academic institutes. The hospitals & surgical centres segment is estimated to proliferate in the coming years due to the rising surgical operations and better reimbursement policies for hospital-based interventions. Geographically, the market is studied across North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa.

North America is projected to witness lucrative growth in this market during the forecast period due to the well-developed healthcare facilities and rising prevalence of stroke & chronic diseases in this region.

Some of the key players operating in the neurovascular devices or interventional neurology market are Johnson & Johnson (US), Medtronic PLC (Ireland), Stryker Corporation (US), Terumo Corporation (Japan), Penumbra, Inc. (US), Microport Scientific Corporation (China), Kaneka Corp. (Japan), Integer Holdings Corporation (US), Balt (France), Perflow Medical (Israel), Phenox GmbH (Germany), Sensome (France), Evasc (Canada), Rapid Medical (Israel), Asahi Intecc Co. Ltd (Japan), Acandis GmbH (Germany), Medikit Co. Ltd (Japan), Imperative Care (US), Lepu Medical (China), Cerus Endovascular (US), MicroVention, Inc. (US), Mizuho Medical (Japan), Peter Lazic GmBH (Germany), Spartan Micro (US), Emboflu (Switzerland), Straub Medical AG (Switzerland), AngioDynamics (US), Microbot Medical Inc. (US) and others.

Companies Mentioned

  • Johnson & Johnson
  • Medtronic PLC
  • Stryker Corporation
  • Terumo Corporation
  • Penumbra, Inc.
  • Microport Scientific Corporation
  • Kaneka Corp.
  • Integer Holdings Corporation
  • Balt
  • Perflow Medical
  • Phenox GmbH
  • Sensome
  • Evasc
  • Rapid Medical
  • Asahi Intecc Co. Ltd
  • Acandis GmbH
  • Medikit Co. Ltd
  • Imperative Care
  • Lepu Medical
  • Cerus Endovascular
  • MicroVention, Inc.
  • Mizuho Medical
  • Peter Lazic GmBH
  • Spartan Micro
  • Emboflu
  • Straub Medical AG
  • AngioDynamics

Microbot Medical Inc.

Chapter 1. Methodology and Scope

1.1. Research Methodology

1.2. Research Scope & Assumptions

Chapter 2. Executive Summary

Chapter 3. Global Neurovascular Devices/Interventional Neurology Market Snapshot

Chapter 4. Global Neurovascular Devices/Interventional Neurology Market Variables, Trends & Scope

4.1. Market Segmentation & Scope

4.2. Drivers

4.3. Challenges

4.4. Trends

4.5. Industry Analysis – Porter’s Five Forces Analysis

4.6. Competitive Landscape & Market Share Analysis

4.7. Clinical Trial/Pipeline Analysis

4.8. COVID 19 Impact Analysis

Chapter 5. Neurovascular Devices/Interventional Neurology Market Segmentation 1: By Products Estimates & Trend Analysis

5.1. By Products & Market Share, 2020 & 2030

5.2. Market Size (Value & Volume) & Forecasts and Trend Analyses, 2020 to 2030 for the following By Products:

5.2.1. Aneurysm Coiling & Embolization Devices

5.2.1.1.  Embolic Coils

5.2.1.1.1.   Bare Detachable Coils

5.2.1.1.2.   Coated Detachable Coils

5.2.1.2.  Flow Diversion Devices

5.2.1.3.  Liquid Embolic Agents

5.2.2. Cerebral Balloon Angioplasty & Stenting Systems

5.2.2.1.  Carotid Artery Stents

5.2.2.2.  Embolic Protection Devices

5.2.2.3.  Balloon Catheters

5.2.3. Support Devices

5.2.3.1.  Microcatheters

5.2.3.2.  Guidewires

5.2.4. Neurothrombectomy devices

5.2.4.1.  Clot Retrievals

5.2.4.2.  Suction & Aspiration Devices

5.2.4.3.  Snares

Chapter 6. Neurovascular Devices/Interventional Neurology Market Segmentation 2: By End-Users Estimates & Trend Analysis

6.1. By End-Users Analysis & Market Share, 2020 & 2030

6.2. Market Size (Value & Volume) & Forecasts and Trend Analyses, 2020 to 2030 for the following By End-Users:

6.2.1. Hospitals & surgical centers

6.2.2. Ambulatory care centers

6.2.3. Research laboratories & academic institutes

Chapter 7. Neurovascular Devices/Interventional Neurology Market Segmentation 3: Regional Estimates & Trend Analysis

7.1. North America

7.1.1. North America Neurovascular Devices/Interventional Neurology Market revenue (US$ Million) and volume (No. of Units) estimates and forecasts By Products, 2020-2030

7.1.2. North America Neurovascular Devices/Interventional Neurology Market revenue (US$ Million) and volume (No. of Units) estimates and forecasts By End-Users, 2020-2030

7.1.3. North America Neurovascular Devices/Interventional Neurology Market revenue (US$ Million) and volume (No. of Units) estimates and forecasts by country, 2020-2030

7.1.3.1. U.S.

7.1.3.2. Canada

7.2. Europe

7.2.1. Europe Neurovascular Devices/Interventional Neurology Market revenue (US$ Million) and volume (No. of Units) By Products, 2020-2030

7.2.2. Europe Neurovascular Devices/Interventional Neurology Market revenue (US$ Million) and volume (No. of Units) By End-Users, 2020-2030

7.2.3. Europe Neurovascular Devices/Interventional Neurology Market revenue (US$ Million) and volume (No. of Units) by country, 2020-2030

7.2.3.1. Germany

7.2.3.2. Poland

7.2.3.3. France

7.2.3.4. Italy

7.2.3.5. Spain

7.2.3.6. UK

7.2.3.7. Rest of Europe

7.3. Asia Pacific

7.3.1. Asia Pacific Neurovascular Devices/Interventional Neurology Market revenue (US$ Million) and volume (No. of Units) By Products, 2020-2030

7.3.2. Asia Pacific Neurovascular Devices/Interventional Neurology Market revenue (US$ Million) and volume (No. of Units) By End-Users, 2020-2030

7.3.3. Asia Pacific Neurovascular Devices/Interventional Neurology Market revenue (US$ Million) and volume (No. of Units) by country, 2020-2030

7.3.3.1. China

7.3.3.2. India

7.3.3.3. Japan

7.3.3.4. Australia

7.3.3.5. Rest of Asia Pacific

7.4. Latin America

7.4.1. Latin America Neurovascular Devices/Interventional Neurology Market revenue (US$ Million) and volume (No. of Units) By Products, (US$ Million) 2020-2030

7.4.2. Latin America Neurovascular Devices/Interventional Neurology Market revenue (US$ Million) and volume (No. of Units) By End-Users, (US$ Million) 2020-2030

7.4.3. Latin America Neurovascular Devices/Interventional Neurology Market revenue (US$ Million) and volume (No. of Units) by country, (US$ Million) 2020-2030

7.4.3.1. Brazil

7.4.3.2. Rest of Latin America

7.5. MEA

7.5.1. MEA revenue Neurovascular Devices/Interventional Neurology Market revenue (US$ Million) and volume (No. of Units) By Products, (US$ Million) 2020-2030

7.5.2. MEA revenue Neurovascular Devices/Interventional Neurology Market revenue (US$ Million) and volume (No. of Units) By End-Users, (US$ Million) 2020-2030

7.5.3. MEA revenue Neurovascular Devices/Interventional Neurology Market revenue (US$ Million) and volume (No. of Units) by country, (US$ Million) 2020-2030

7.5.3.1. South Africa

7.5.3.2. Rest of MEA

Chapter 8. Competitive Landscape

8.1. Major Mergers and Acquisitions/Strategic Alliances

8.2. Company Profiles

8.2.1. Johnson & Johnson (US)

8.2.2. Medtronic PLC (Ireland)

8.2.3. Stryker Corporation (US)

8.2.4. Terumo Corporation (Japan)

8.2.5. Penumbra, Inc. (US)

8.2.6. Microport Scientific Corporation (China)

8.2.7. Kaneka Corp. (Japan)

8.2.8. Integer Holdings Corporation

8.2.9. Balt (France)

8.2.10. Perflow Medical

8.2.11. Phenox GmbH (Germany)

8.2.12. Sensome (France)

8.2.13. Evasc (Canada)

8.2.14. Rapid Medical (Israel)

8.2.15. Asahi Intecc Co. Ltd (Japan)

8.2.16. Acandis GmbH (Germany)

8.2.17. Medikit Co. Ltd (Japan)

8.2.18. Imperative Care (US)

8.2.19. Lepu Medical (China)

8.2.20. Cerus Endovascular (US)

8.2.21. MicroVention, Inc.

8.2.22. Mizuho Medical

8.2.23. Peter Lazic GmBH

8.2.24. Spartan Micro

8.2.25. Emboflu

8.2.26. Straub Medical AG

8.2.27. AngioDynamics

8.2.28. Stryker Corporation

Global Neurovascular Devices or Interventional Neurology Market, by Products, 2020-2030, Value (US$ Mn) and Volume (No. of Units)

  • Aneurysm Coiling & Embolization Devices
  • Embolic Coils
  • Bare Detachable Coils
  • Coated Detachable Coils
  • Flow Diversion Devices
  • Liquid Embolic Agents
  • Cerebral Balloon Angioplasty & Stenting Systems
  • Carotid Artery Stents
  • Embolic Protection Devices
  • Balloon Catheters
  • Support Devices
  • Microcatheters
  • Guidewires
  • Neurothrombectomy devices
  • Clot Retrievals
  • Suction & Aspiration Devices
  • Snares

Global Neurovascular Devices or Interventional Neurology Market, by End-Users, 2020-2030, Value (US$ Mn) and Volume (No. of Units)

  • Hospitals & Surgical Centers
  • Ambulatory Care Centers
  • Research Laboratories & Academic Institutes

Global Neurovascular Devices or Interventional Neurology Market, by Region, 2020-2030, Value (US$ Mn) and Volume (No. of Units)

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa

North America Neurovascular Devices or Interventional Neurology Market, by Country, 2020-2030, Value (US$ Mn) and Volume (No. of Units)

  • U.S.
  • Canada

Europe Neurovascular Devices or Interventional Neurology Market, by Country, 2020-2030, Value (US$ Mn) and Volume (No. of Units)

  • Germany
  • France
  • Italy
  • Spain
  • Russia
  • Rest of Europe

Asia Pacific Neurovascular Devices or Interventional Neurology Market, by Country, 2020-2030, Value (US$ Mn) and Volume (No. of Units)

  • India
  • China
  • Japan
  • South Korea
  • Australia & New Zealand

Latin America Neurovascular Devices or Interventional Neurology Market, by Country, 2020-2030, Value (US$ Mn) and Volume (No. of Units)

  • Brazil
  • Mexico
  • Rest of Latin America

Middle East & Africa Neurovascular Devices or Interventional Neurology Market, by Country, 2020-2030, Value (US$ Mn) and Volume (No. of Units)

  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Landscape

  • Company Overview
  • Financial Performance
  • Key Development
  • Latest Strategic Developments

InsightAce Analytic follows a standard and comprehensive market research methodology focused on offering the most accurate and precise market insights. The methods followed for all our market research studies include three significant steps – primary research, secondary research, and data modeling and analysis - to derive the current market size and forecast it over the forecast period. In this study, these three steps were used iteratively to generate valid data points (minimum deviation), which were cross-validated through multiple approaches mentioned below in the data modeling section.

Through secondary research methods, information on the market under study, its peer, and the parent market was collected. This information was then entered into data models. The resulted data points and insights were then validated by primary participants.

Based on additional insights from these primary participants, more directional efforts were put into doing secondary research and optimize data models. This process was repeated till all data models used in the study produced similar results (with minimum deviation). This way, this iterative process was able to generate the most accurate market numbers and qualitative insights.

Secondary research

The secondary research sources that are typically mentioned to include, but are not limited to:

  • Company websites, financial reports, annual reports, investor presentations, broker reports, and SEC filings.
  • External and internal proprietary databases, regulatory databases, and relevant patent analysis
  • Statistical databases, National government documents, and market reports
  • Press releases, news articles, and webcasts specific to the companies operating in the market

The paid sources for secondary research like Factiva, OneSource, Hoovers, and Statista

Primary Research:

Primary research involves telephonic interviews, e-mail interactions, as well as face-to-face interviews for each market, category, segment, and subsegment across geographies

The contributors who typically take part in such a course include, but are not limited to: 

  • Industry participants: CEOs, CBO, CMO, VPs, marketing/ type managers, corporate strategy managers, and national sales managers, technical personnel, purchasing managers, resellers, and distributors.
  • Outside experts: Valuation experts, Investment bankers, research analysts specializing in specific markets
  • Key opinion leaders (KOLs) specializing in unique areas corresponding to various industry verticals
  • End-users: Vary mainly depending upon the market

Data Modeling and Analysis:

In the iterative process (mentioned above), data models received inputs from primary as well as secondary sources. But analysts working on these models were the key. They used their extensive knowledge and experience about industry and topic to make changes and fine-tuning these models as per the product/service under study.

The standard data models used while studying this market were the top-down and bottom-up approaches and the company shares analysis model. However, other methods were also used along with these – which were specific to the industry and product/service under study.

To know more about the research methodology used for this study, kindly contact us/click here.

Need Complete Report ?

Frequently Asked Questions

Who are the Key Players in the Global Neurovascular Devices or Interventional Neurology Market?

US$ 2.66 billion in 2021

annual growth rate (CAGR) of 9.13% from 2022 to 2030.

Our Clients